-
Medical journals
- Career
Forum Diabetologicum - Issue 2/2020
87Niekoľko slov úvodomprof. MUDr. Marián Mokáň, DrSc., Frcp Edin
Editorial
91Heart failure at the time of “diabetes epidemic“Eva Gon Alvesová
95Pathophysiological aspects of chronic heart failureAndrej Dukát, Juraj Payer, Ján Gajdošík, Valentín Szabó, Fedor Šimko
98Chronic heart failure: a minimum for diabetologistEva Gon Alvesová
104SGLT2 inhibitors in the treatment of diabetes mellitusPeter Jackuliak, Magdaléna Kovářová, Juraj Payer
110Use of glucometers in the care of patients with diabetes mellitusDana Prídavková, Udovít Šutarík, Peter Galajda, Marián Mokáň
115Gliflozins and heart: Analyses of EMPRISE studyMarián Mokáň, Peter Galajda
121Gliflozins and kidney: Analyses of CREDENCE studyMarián Mokáň, Peter Galajda
125Liečba inhibítormi SGLT2 u pacientov so srdcovým zlyhávaním: Čo priniesla štúdia DAPA-HF pre kardiovaskulárnu diabetológiu?Andrej Dukát, Milan Kriška, Juraj Payer
128Relationship between overweight and obesity with the development of cardiovascular diseasesJán Murín, Udovít Gašpar
132Autodidaktický test hodnotený kreditmi ARS CMEDana Prídavková
Forum Diabetologicum
Most read in this issue- SGLT2 inhibitors in the treatment of diabetes mellitus
- Liečba inhibítormi SGLT2 u pacientov so srdcovým zlyhávaním: Čo priniesla štúdia DAPA-HF pre kardiovaskulárnu diabetológiu?
- Pathophysiological aspects of chronic heart failure
- Gliflozins and heart: Analyses of EMPRISE study
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career